ProMIS Neurosciencesの売上総利益
ProMIS Neurosciencesの売上総利益 は何ですか。
ProMIS Neurosciences, Inc.の売上総利益 は-46,300.00%です。
売上総利益 の定義は何ですか。
売上総利益は、売上と商品の売上原価との差を収益で除してパーセンテージで表したものです。
Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.
TSXのセクタHealth Careにおける売上総利益 の企業と比べるProMIS Neurosciences
ProMIS Neurosciencesは何をしますか。
ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a superoxide dismustase 1 and TAR-DNA binding protein 43 in ALS, as well as alpha synuclein in Parkinson's disease and Lewy body dementia; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils in MSA. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.
ProMIS Neurosciencesと類似の売上総利益
- Peak Resourcesの売上総利益 は-78,111.11%です。
- NeuroVive Pharmaceutical ABの売上総利益 は-68,572.19%です。
- NeuroVive Pharmaceutical ABの売上総利益 は-68,572.19%です。
- ProMIS Neurosciencesの売上総利益 は-60,710.44%です。
- Eco (Atlantic) Oil & Gasの売上総利益 は-54,253.94%です。
- Solarvest Bioの売上総利益 は-47,000.00%です。
- ProMIS Neurosciencesの売上総利益 は-46,300.00%です。
- Magnis Resourcesの売上総利益 は-45,793.10%です。
- Pure Mineralsの売上総利益 は-44,700.00%です。
- Condor Technologies NVの売上総利益 は-41,600.00%です。
- CytoDynの売上総利益 は-27,547.74%です。
- Aqua Metals Incの売上総利益 は-25,028.00%です。
- Alpha HPAの売上総利益 は-22,812.50%です。